Bhaskar Anand - Apr 29, 2025 Form 4 Insider Report for Summit Therapeutics Inc. (SMMT)

Role
Chief Accounting Officer
Signature
/s/ Bhaskar Anand
Stock symbol
SMMT
Transactions as of
Apr 29, 2025
Transactions value $
$0
Form type
4
Date filed
5/1/2025, 06:17 PM
Previous filing
Jan 14, 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SMMT Stock Option (right to buy) Award +600K 600K Apr 29, 2025 Common Stock 600K $3.85 Direct F1, F2
transaction SMMT Stock Option (right to buy) Award +75K 75K Apr 29, 2025 Common Stock 75K $17.85 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Effective April 29, 2025, these stock options were amended from performance-based stock options to time-based stock options. The shares underlying the option vest in four equal annual installments, with the first such installment occurring on December 31, 2025.
F2 Not applicable.
F3 Effective April 29, 2025, these stock options were amended from performance-based stock options to time-based stock options. The shares underlying the option vest in four equal annual installments, with the first such installment occurring on January 12, 2026.